Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Speciality Medicines Rescue GSK’s Q3 As Vaccines Sales Slump

Oct 30 2024

• By Andrew McConaghie

New GSK sign — • Source: Shutterstock

Related Content

GSK’s Antibiotic Gepotidacin Nears Approval Line

Oct 16 2024

RSV Vaccines: ACIP Recommendations For Adults Younger Than Age 60 Await More Data

Nov 08 2024

GSK Lifted By $2.2bn Zantac Litigation Deal

Oct 10 2024

Related Companies

GSK plc

Additional Topics

Sales & Earnings Vaccines

More from Earnings

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window